# Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/atezolizumab-plus-bevacizumab-and-chemotherapy-in-non-small-cell-lung-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Martin Reck,Tony Mok,Makoto Nishio,Robert M. Jotte,Federico Cappuzzo,Francesco Orlandi,Daniil Stroyakovskiy,Naoyuki Nogami,Delvys Rodríguez‐Abreu,Denis Moro‐Sibilot,Christian A. Thomas,Fabrice Barlési,Gene Finley,Anthony Lee,Shelley Coleman,Yu Deng,Marcin Kowanetz,Geetha Shankar,Wei Lin,Mark A Socinski,Martin Reck,Tony Mok,Makoto Nishio,Robert M. Jotte,Federico Cappuzzo,Francesco Orlandi,Daniil Stroyakovskiy,Naoyuki Nogami,Delvys Rodríguez‐Abreu,Denis Moro‐Sibilot,Christian A. Thomas,Fabrice Barlési,Gene Finley,Anthony Lee,Shelley Coleman,Yu Deng,Marcin Kowanetz,Geetha Shankar,Wei Lin,Mark A Socinski |
| Citations | 947 |
| DOI | 10.1016/s2213-2600(19)30084-0 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2924289105 |
| PMID | 30922878 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Denis Moro‐Sibilot](https://scholariq.org/researchers/denis-moro-sibilot/)

## Paper journal

- [The Lancet Respiratory Medicine](https://scholariq.org/journals/the-lancet-respiratory-medicine/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.